 |
Abbott is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Their products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years. |
|
 |
Actavis is one of the world’s leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. Founded in 1956, the Company has led an assertive programme of expansion, making more than 20 acquisitions in the past seven years while maintaining strong organic growth. The Group has approximately 11,000 employees operating in about 40 countries around the globe. Actavis’ headquarters are in Iceland. |
|
 |
Alkaloid is a company that for seven decades now is in the business of manufacturing drugs, processing botanical raw material, manufacturing cosmetics and chemical products. Alkaloid is a company with a fantastic grow rate. |
|
 |
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Their products and services are designed to benefit people and improve their quality of life. At the same time they want to create value through innovation, growth and high earning power. Bayer is also one of our greatest partners. |
|
 |
BERLIN-CHEMIE is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company. |
|
 |
Beiersdorf AG (FWB: BEI) is a multinational corporation based in Hamburg, Germany, manufacturing personal care products. Our brands enjoy universal trust – from NIVEA, the world’s largest skin and beauty care brand, through the medical skin care brand Eucerin, down to luxurious anti-age care from la prairie.
The basis of our success are our leading international brands and more than 125 years of experience in research and development, and our strong international presence. |
|
 |
EGIS PLC is one of the leading, vertically integrated pharmaceutical companies in Central Eastern Europe with activities extending to every field of pharmaceutical production from generic and original R&D, through active ingredient and finished production to sales and marketing. |
|
 |
Production and distribution of generic drugs is core business of Farmal d.d. Considering the situation on the global pharmaceutical market and the huge trend of applying generic drugs in all health institutions, in 1999 they’ve started a pharmaceutical production. Farmal’s main goal is to crest a modern and flexible pharmaceutical company based on the production of generic drugs which will provide health oriented knowledge and services. |
|
 |
Glaxo is one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria, and are very proud to have developed some of the leading global medicines in these fields. GSK runs the trends. |
|
 |
Grünenthal is an international family-owned pharmaceutical company with its head office in Germany. They are specialized in the field of pain therapy and contraception and tread trend-setting paths.
The development and marketing of innovative formulations for established active substances are aspects on which we particularly focus. The company, founded in 1946, markets its products in approx. 100 countries; in addition Grünenthal is internationally active with seven production sites and companies in 29 countries. Grünenthal employs approximately 4800 people world-wide – 1900 in Germany. |
|
 |
Krka is one of the top generic pharmaceutical companies in Europe. They actively penetrated the western markets and at the same time kept their advantage in their traditional markets, from Vladivostok to Dublin.
For half of the century Krka is successfully realising their strategic goals and doing that. Krka is one of the top developing European leading generic pharmaceutical companies. With a strong leadership and excellence strategic goals they have become a synonym for success. |
|
 |
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for active pharmaceutical ingredients and medicines, as a competence center for the development of vertically integrated products, as a Sandoz competence center in the field of development and manufacturing of biopharmaceutical products and as a supply center for the markets of CEE, SEE and CIS, sales Slovenia and sales services for Sandoz’s global markets. |
|
 |
Medis, established in 1989, is a company focused on marketing of pharmaceutical products in Central and Southeast Europe. This region of smaller markets, which is outside the primary focus of many healthcare companies due to logistic impracticality and financial risks, is Medis specialty. They offer one delivery and billing point that covers the regional market of Slovenia, Hungary, Slovakia, Czech Republic, Croatia, Serbia, Bosnia and Herzegovina, Kosovo, Monte Negro, Macedonia, and Albania. |
|
 |
The L’Oréal Group is the world’s largest cosmetics and beauty company. With its registered office in Paris and head office in the Paris suburb of Clichy, Hauts-de-Seine, France, it has developed activities in the field of cosmetics. Concentrating on hair color, skin care, sun protection, make-up, perfumes and hair care, the company is active in the dermatological and pharmaceutical fields and is the top nanotechnology patent-holder in the United States. L’Oreal was founded in 1909 and today employees around the globe 67.000 people. |
|
 |
PharmaS is a new established Croatian generic company. Currently PharmaS is present on the Central European market. |
|
 |
Pfizer is the world’s largest research-based biomedical and pharmaceutical company. Pfizer is committed to being a global leader in health care and to helping change millions of lives for the better through providing access to safe, effective and affordable medicines and related health care services to the people who need them. They have a leading portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas, and an industry-leading pipeline of promising new products in areas such as oncology, cardiovascular disease and diabetes. |
|
 |
Merck Serono is a pharmaceutical company headquartered in Geneva In September 2006, Merck announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family. The Merck-Serono merger was announced on September 21, 2006. Merck KGaA and Serono operated as distinct entities until at least January 2007. As of January 5, 2007, Merck held the majority shares of Serono. The new company is called Merck Serono International S.A. |
|
 |
Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio. Its R&D is structured around partnerships and in-licensing is a cornerstone of the company’s growth strategy. Nycomed employs 12,000 associates worldwide, and is headquartered in Zurich, Switzerland. |
|
